<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03527342</url>
  </required_header>
  <id_info>
    <org_study_id>SUCARD</org_study_id>
    <nct_id>NCT03527342</nct_id>
  </id_info>
  <brief_title>Sahlgrenska Cardiomyopathy Project</brief_title>
  <official_title>Sahlgrenska University Hospital Cardiomyopathy Project: Mapping and Diagnosis of Cardiomyopathies to Enable Early and Specific Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal.

      Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP)
      including in depth clinical and molecular phenotyping to enable earlier and specific
      treatment. The project will serve as:

        1. resource for diagnostic and therapeutic trials

        2. common biomaterial bank

        3. resource for detailed molecular analyses on patients' biomaterials and patient specific
           symptoms and examination results
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">January 2029</completion_date>
  <primary_completion_date type="Anticipated">January 2028</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Time to disease progression</measure>
    <time_frame>2018-2028</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Progression in biomarker NT-proBNP</measure>
    <time_frame>2018-2028</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes over time in presence of autoantibodies</measure>
    <time_frame>2018-2028</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Disease activity evaluated by positron-emissions-tomography computed tomography (PET-CT)</measure>
    <time_frame>2018-2028</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Disease activity evaluated by magnetic resonance imaging (MRI)</measure>
    <time_frame>2018-2028</time_frame>
  </other_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Dilated Cardiomyopathies</condition>
  <condition>Hypertrophic Cardiomyopathy</condition>
  <condition>Restrictive Cardiomyopathy</condition>
  <condition>Arrhythmogenic Right Ventricular Cardiomyopathy</condition>
  <condition>Myocarditis</condition>
  <condition>Sarcoidosis With Myocarditis</condition>
  <condition>Giant Cell Myocarditis</condition>
  <condition>Amyloidosis; Heart (Manifestation)</condition>
  <arm_group>
    <arm_group_label>Dilated Cardiomyopathy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Myocarditis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Sarcoidosis Heart</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Giant Cell Myocarditis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Amyloidosis Heart</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypertrophic Cardiomyopathies</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Left Ventricular Myocardial Noncompaction Cardiomyopathy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Arrhythmogenic Right Ventricular Cardiomyopathies</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible patients are all patients referred to Sahlgrenska University Hospital, Gothenburg,
        Sweden with a cardiomyopathy diagnose.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with primary cardiomyopathies including hereditary and inflammatory dilated
             cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left
             ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular
             cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis
             engaging the heart

        Exclusion Criteria:

          -  Patient with other preexisting cardiac diseases such as significant valvular, ischemic
             or pericardial disease before they receive a cardiomyopathy diagnose

          -  patients &lt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>NIklas Bergh, PhD</last_name>
    <phone>+46313421000</phone>
    <email>niklas.bergh@vgregion.se</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>May 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Göteborg University</investigator_affiliation>
    <investigator_full_name>Niklas Bergh</investigator_full_name>
    <investigator_title>Associate Professor, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
    <mesh_term>Myocarditis</mesh_term>
    <mesh_term>Arrhythmogenic Right Ventricular Dysplasia</mesh_term>
    <mesh_term>Cardiomyopathy, Restrictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

